Vertiv Holdings Co (VRT)

Achilles Therapeutics Revenue

Vertiv Holdings Co had revenue of $2.64B in the quarter ending June 30, 2025, with 35.09% growth. This brings the company's revenue in the last twelve months to $9.09B, up 26.31% year-over-year. In the year 2024, Vertiv Holdings Co had annual revenue of $8.01B with 16.74% growth.

• Revenue (ttm): $9.09B
• Revenue Growth: +26.31%
• P/S Ratio: 5.82
• Revenue / Employee: $293,355
• Employees: 31,000
• Market Cap: 53.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.01B	1.15B	16.74%
Dec 31, 2023	6.86B	1.17B	20.59%
Dec 31, 2022	5.69B	693.40M	13.87%
Dec 31, 2021	5.00B	627.50M	14.36%
Dec 31, 2020	4.37B	-60.60M	-1.37%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.